The neuronal endosomal-lysosomal system in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 3, Issue 1, 2001, Pages 97-107

  Nixon, Ralph A ^a,b,c   Mathews, Paul M ^a,b,c   Cataldo, Anne M ^a,b,c  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CATHEPSIN; PROTEINASE;

ALZHEIMER DISEASE; AMYLOIDOSIS; AUTOPHAGY; CELL DEATH; DOWN SYNDROME; ENDOCYTOSIS; ENDOSOME; HUMAN; LYSOSOME; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

EID: 0035078189     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2001-3114     Document Type: Review

References (113)

1. Lysosomal dysfunction reduces brain-derived neurotrophic factor expression
2. Suppression of cathepsins B and L causes a proliferation of lysosomes and the formation of meganeurites in hippocampus
3. Immunodetection of cathepsin D in neuritic plaques found in brains of patients with dementia of Alzheimer type
4. Regulation and expression of the Alzheimer's beta/A4 amyloid protein precursor in health, disease, and Down's syndrome
5. Alpha-2 macroglobulin is genetically associated with Alzheimer disease
6. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta 1-42/1-40 ratio in vitro and in vivo
7. Do GTPases direct membrane traffic in secretion?
8. Photo-oxidative disruption of lysosomal membranes causes apoptosis of cultured human fibroblasts
9. The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway
10. Differential localization of cysteine protease inhibitors and a target cysteine protease, cathepsin B, by immunoconfocal microscopy
11. Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer disease neurons containing neurofibrillary tangles
12. Endocytic pathway abnormalities precede beta-amyloid deposition in sporadic Alzheimer's disease: Differential effects of APOE genotype and presenilin mutations
13. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal- lysosomal system
14. Colocalization of lysosomal hydrolase and beta-amyloid in diffuse plaques of the cerebellum and striatum in Alzheimer's disease and Down's syndrome
15. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: Neuropathologic evidence for a mechanism of increased beta-amyloidogenesis
16. Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease
17. Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease
18. Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: Evidence for a neuronal origin
19. Localization of low molecular weight GTP binding proteins to exocytic and endocytic compartments
20. Cathepsin D displays in vitro beta-secretase-like specificity
21. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice
22. Molecular aspects of the endocytic pathway
23. Caspases: The executioners of apoptosis
24. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
25. The cystatin C gene as a novel genetic risk factor for late onset Alzheimer's disease
26. Rab4 and cellubrevin define different early endosome populations on the pathway of transferrin receptor recycling
27. The involvement of the small GTP-binding protein Rab5a in neuronal endocytosis
28. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha
29. Processing of the pre-beta-amyloid protein by cathepsin D is enhanced by a familial Alzheimer's disease mutation
30. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1
31. Candidate gamma-secretases in the generation of the carboxyl terminus of the Alzheimer's disease beta A4 amyloid: Possible involvement of cathepsin D
32. Association between bleomycin hydrolase and Alzheimer's disease in caucasians
33. Cell death induced by peroxidized low-density lipoprotein: Endopepsis
34. Tau protein and the neurofibrillary pathology of Alzheimer's disease
35. Rab5 controls early endosome fusion in vitro
36. Peptidyl diazomethyl ketones are specific inactivators of thiol proteinases
37. Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism
38. Apolipoprotein E binds to and potentiates the biological activity of ciliary neurotrophic factor
39. Amyloid beta-peptide is produced by cultured cells during normal melabolism
40. Cathepsin D targeted by acid sphingomyelinase-derived ceramide
41. Oxidant-induced apoptosis: A consequence of lethal lysosomal leak?
42. Dementia of the Alzheimer type. Clinical genetics, natural history, and associated conditions
43. ApoE genotype is a risk factor in nonpresenilin early-onset Alzheimer's disease families
44. The human FE65 gene: Genomic structure and an intronic biallelic polymorphism associated with sporadic dementia of the Alzheimer type
45. Regulation of a novel pathway for cell death by lysosomal aspartic and cysteine proteinases
46. Participation of a cathepsin L-type protease in the activation of caspase-3
47. Anomalous accumulation of tau and ubiquitin immunoreactivities in rat brain caused by protease inhibition and by normal aging: A clue to PHF pathogenesis?
48. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: Evidence that an initially deposited species is A beta 42(43)
49. Isoform-specific effect of apolipoprotein E on cell survival and beta- amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures
50. Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor-related protein gene
51. Determinants of the apoptotic response to lysosomal photodamage
52. Evidence that production and release of amyloid beta-protein involves the endocytic pathway
53. The biogenesis of lysosomes
54. Apolipoprotein E and the CNS response to injury
55. Uptake of oxidized LDL by macrophages results in partial lysosomal enzyme inactivation and relocation
56. Genetic association of an alpha2-macroglobulin (Va1100011e) polymorphism and Alzheimer's disease
57. Familial and sporadic Alzheimer's disease: Neuropathology cannot exclude a final common pathway
58. A possible role for cathepsins D, E, and B in the processing of beta- amyloid precursor protein in Alzheimer's disease
59. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
60. Lysosomal system activation in presenilin I-linked familial Alzheimer's disease
61. Accelerated Aβ Generation in a model of Alzheimer's Disease - Related endosomatlysosomal systemupregulation
62. Beta-Amyloid precursor protein metabolites and loss of neuronal Ca2 + homeostasis in Alzheimer's disease
63. Cell and molecular neurobiology of presenilins: A role for the endoplasmic reticulum in the pathogenesis of Alzheimer's disease?
64. Cathepsin D gene exon 2 polymorphism and sporadic Alzheimer's disease
65. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides
66. Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease
67. Genetic and molecular advances in Alzheimer's disease
68. Abnormal distribution of cathepsins in the brain of patients with Alzheimer's disease
69. Association of interleukin-1 gene polymorphisms with Alzheimer's disease
70. The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: A review
71. The lysosomal system in neuronal cell death: A review
72. The endosomal-lysosomal system of neurons: New roles
73. Friends and family: The role of the Rab GTPases in vesicular traffic
74. Inhibition of cathepsin D prevents free-radical-induced apoptosis in rat cardiomyocytes
75. Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease
76. A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease
77. Evidence that luminal ER proteins are sorted from secreted proteins in a post-ER compartment
78. Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice
79. Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover and the generation of secreted fragments, including Abeta42
80. Detection of apolipoprotein E/dimeric soluble amyloid beta complexes in Alzheimer's disease brain supernatants
81. Protease activities in normal and schizophrenic human prefrontal cortex and white matter
82. Lysosomal release of cathepsin D precedes relocation of cytochrome c and loss of mitochondrial transmembrane potential during apoptosis induced by oxidative stress
83. Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes
84. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome I related to the Alzheimer's disease type 3 gene
85. Heterologous transmembrane and cytoplasmic domains direct functional chimeric influenza virus hemagglutinins into the endocytic pathway
86. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
87. Elevated levels of the endosomal-lysosomal proteinase cathepsin D in cerebrospinal fluid in Alzheimer disease
88. Non-selective autophagy
89. Physiological production of the beta-amyloid protein and the mechanism of Alzheimer's disease
90. Normal and abnormal biology of the beta-amyloid precursor protein
91. Notch and presenilins in vertebrates and invertebrates: Implications for neuronal development and degeneration
92. EEAI links PI(3)K function to Rab5 regulation of endosome fusion
93. Role of the Secretory and Endocytic Pathways in the Production of Amyloid beta-peptides alpha-beta 1-40 and alpha-beta 1-42
94. 46-kDa mannose 6-phosphate-specific receptor: Biosynthesis, processing, subcellular location and topology
95. Mr 46,000 mannose 6-phosphate specific receptor: Its role in targeting of lysosomal enzymes
96. Rabaptin-5 is a direct effector of the small GTPase Rab5 in endocytic membrane fusion
97. The pathway of alpha-beta 42 production in APP with codon 717 mutation
98. The gene defects responsible for familial Alzheimer's disease
99. Missense polymorphism (C/T224) in the human cathepsin D pro-fragment determined by polymerase chain reaction - Single strand conformational polymorphism analysis and possible consequences in cancer cells
100. Presenilins and Alzheimer disease
101. The small GTP-binding protein rab4 controls an early sorting event on the endocytic pathway
102. Caspase-mediated fragmentation of calpain inhibitor protein calpastatin during apoptosis
103. Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease
104. Relative efficacies of amyloid beta peptide (A beta) binding proteins in A beta aggregation
105. Alzheimer's disease in Down's syndrome: Clinicopathologic studies
106. Participation of presenilin 2 in apoptosis: Enhanced basal activity conferred by an Alzheimer mutation
107. Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E
108. Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity
109. Genetic risk factors in Japanese Alzheimer's disease patients: Alpha1-ACT, VLDLR, and ApoE
110. Inhibition of ischaemic hippocampal neuronal death in primates with cathepsin B inhibitor CA-074: A novel strategy for neuroprotection based on 'calpain-cathepsin hypothesis'
111. Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis
112. Rab GTPases in vesicular transport